Skip to main content
. 2015 Oct 22;39(5):414–423. doi: 10.4093/dmj.2015.39.5.414

Table 1. Clinical and biochemical characteristics of the study population according to serum total bilirubin tertiles.

Variable Total bilirubin tertile P value
T1 (<12 µmol/L) T2 (12-17 µmol/L) T3 (>17 µmol/L)
Number 154 154 152
Age, yr 63.9±8.9 62.8±8.9 62.2±6.8 0.177
Male sex 95 (62) 93 (60) 98 (64) 0.617
Duration of diabetes, yr 15.2±8.4 13.4±7.8 11.4±7.2 <0.001
Body mass index, kg/m2 24.8±2.8 25.0±3.3 25.4±3.0 0.236
Hypertension 93 (60) 80 (52) 76 (50) 0.068
SBP, mm Hg 135.5±16.7 131.5±14.8 131.7±15.0 0.04
DBP, mm Hg 78.1±8.8 77.6±8.5 78.3±9.3 0.777
Current smoking 46 (30) 33 (21) 27 (18) 0.012
HbA1c, % 57 (50-68) 56 (46-69) 56 (49-67) 0.568
Total cholesterol, mmol/L 4.5±0.9 4.6±0.9 4.5±0.9 0.67
LDL-C, mmol/L 2.8±0.8 2.9±0.8 2.8±0.8 0.317
HDL-C, mmol/L 1.2±0.3 1.3±0.3 1.3±0.3 0.017
Triglyceride, mmol/L 1.5 (1.1-2.0) 1.3 (1.0-1.9) 1.3 (1.0-1.6) 0.045
Diabetic retinopathy 73 (47) 56 (36) 45 (30) 0.001
Diabetic nephropathy 50 (33) 28 (18) 19 (13) <0.001
eGFR, mL/min/1.73 m2 79.0±16.5 81.0±15.7 84.2±15.0 0.015
Insulin use 32 (21) 25 (16) 22 (14) 0.144
Statin use 35 (23) 38 (25) 33 (22) 0.835
AST, IU/L 23.4±8.0 24.8±10.1 24.6±9.1 0.381
ALT, IU/L 23.1±9.8 23.2±10.6 25.0±12.7 0.229
Alcohol intake, g/day 0.538
 <5 107 (69) 111 (72) 102 (67)
 5-30 35 (23) 34 (22) 35 (23)
 >30 12 (8) 9 (6) 15 (10)
Framingham 10-year risk, % 17.8±8.2 15.6±7.4 14.7±7.3 0.002

Values are presented as mean±standard deviation, number (%), or median (interquartile range).

SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, glycosylated hemoglobin; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate; AST, aspartate aminotransferase; ALT, alanine aminotransferase.